Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.
about
Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical PracticeBone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy -a prospective observational study.Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trialThe RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone healthDairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected Mediterranean subjects.Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice.Increased bone resorption during tenofovir plus lopinavir/ritonavir therapy in Chinese individuals with HIVThe ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavirRole of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.Different Impact Of Antiretroviral Drugs On Bone Differentiation In An In Vitro Model.Longitudinal increase in vitamin D binding protein levels after initiation of tenofovir/lamivudine/efavirenz among individuals with HIV.Bone mineral density changes after 2 years of ARV treatment, compared to naive HIV-1-infected patients not on HAART.An increased risk for fractures: another cause of frailty in HIV-infected subjects.Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection.Mexican patients with HIV have a high prevalence of vertebral fractures.Continued Interest and Controversy: Vitamin D in HIV.
P2860
Q28554567-D47BD21B-1C9D-455F-B318-0434AE1001E5Q31124706-60DBAAE0-7D6A-4606-9AA3-BEF185BD8BCAQ33604322-82224B3A-637F-4409-805F-A2B43DC71B6BQ34110585-20CEBFF7-9DB6-4055-9C41-48D76122F49FQ34380767-40A556FF-6523-40D2-A59B-97E678D367C5Q34475217-12EE84EA-7275-4766-A99B-2A0206B540F5Q35102114-D2FC8EB2-EA50-490B-A680-C37A3F158984Q37279429-A2D7DCD2-0D94-4F45-814D-2D56ECEF72C2Q37344527-85E0C7CA-29A5-4D27-A010-74C54D4B3CCBQ38055705-25770A02-73F6-41B7-9889-4DC7E655A6A4Q38895284-F78D2A46-EBAD-4AAA-8CFB-0D9B0FADC857Q39813500-71A28F45-951E-418E-8F49-D18DCD966867Q41647237-31426134-2847-4AD2-9596-79D43251004CQ44807343-199EC335-3C28-4ABF-9E65-32F7705CCB5FQ52664377-48B6A378-D6A3-4155-BEE4-388641948570Q54222374-38DCC3AA-B6F8-4630-9D22-9BB1A9FA205CQ54224147-CF065F34-70DE-414B-820C-3ADEC7795581
P2860
Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Prospective evaluation of bone ...... anavir/ritonavir or efavirenz.
@ast
Prospective evaluation of bone ...... anavir/ritonavir or efavirenz.
@en
Prospective evaluation of bone ...... anavir/ritonavir or efavirenz.
@nl
type
label
Prospective evaluation of bone ...... anavir/ritonavir or efavirenz.
@ast
Prospective evaluation of bone ...... anavir/ritonavir or efavirenz.
@en
Prospective evaluation of bone ...... anavir/ritonavir or efavirenz.
@nl
prefLabel
Prospective evaluation of bone ...... anavir/ritonavir or efavirenz.
@ast
Prospective evaluation of bone ...... anavir/ritonavir or efavirenz.
@en
Prospective evaluation of bone ...... anavir/ritonavir or efavirenz.
@nl
P2093
P2860
P356
P1476
Prospective evaluation of bone ...... anavir/ritonavir or efavirenz.
@en
P2093
Alberto Clò
Alessandra Calabresi
Bruno Mario Cesana
Carlo Torti
Daria Gotti
Davide Gibellini
Davide Motta
Emanuele Focà
Ilaria Izzo
Laura Albini
P2860
P2888
P356
10.1186/1471-2334-12-38
P577
2012-02-14T00:00:00Z
P5875
P6179
1043691986